THIRD AVENUE MANAGEMENT LLC

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1099281 NEW YORK, NY

Position in SUPN

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$7,894,303

-$1,523,499 QoQ

Shares Held

152,724

-19.4% QoQ

Ownership

0.263%

of shares outstanding

% of Portfolio

1.34%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2022

16 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

THIRD AVENUE MANAGEMENT LLC holds $13,024,882 across 2 Drug Manufacturers - Specialty & Generic names. SUPN ranks #1 (60.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)	Open
1	SUPN	Supernus Pharmaceuticals, Inc. This page	152,724	$7,894,303
2	COLL	Collegium Pharmaceutical, Inc	155,143	$5,130,579

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,894,303	152,724	-19.4%	Shares	Sole	2026-05-13
2025-12-31	$9,417,802	189,493	0.0%	Shares	Sole	2026-02-12
2025-09-30	$9,055,870	189,493	0.0%	Shares	Sole	2025-11-14
2025-06-30	$5,972,819	189,493	0.0%	Shares	Sole	2025-08-13
2025-03-31	$6,205,895	189,493	0.0%	Shares	Sole	2025-05-14
2024-12-31	$6,852,066	189,493	0.0%	Shares	Sole	2025-02-13
2024-09-30	$5,908,391	189,493	+0.2%	Shares	Sole	2024-11-14
2024-06-30	$5,058,906	189,118	+18.4%	Shares	Sole	2024-08-13
2024-03-31	$5,447,946	159,717	0.0%	Shares	Sole	2024-05-13
2023-12-31	$4,622,209	159,717	+37.0%	Shares	Sole	2024-02-14
2023-09-30	$3,213,255	116,549	+73.8%	Shares	Sole	2023-11-15
2023-06-30	$2,015,883	67,062	+2626.1%	Shares	Sole	2023-08-14
2023-03-31	$89,125	2,460	0.0%	Shares	Sole	2023-05-16
2022-12-31	$87,748	2,460	0.0%	Shares	Sole	2023-02-10
2022-09-30	$83,271	2,460	0.0%	Shares	Sole	2022-11-14
2022-06-30	$71,143	2,460	—	Shares	Sole	2022-08-12
No filing history on record for this holder in this stock.